1-8 of 8
Philip S. Boonstra
Close
Sort by
Journal Articles

A Multi-Center Study: Outcomes Among Relapsed/Refractory Diffuse Large B Cell Lymphoma Patients with CD20 Loss

Radhika Takiar, Wern Lynn Ng, Eshana Shah, Philip S. Boonstra, Yasmin H. Karimi, Shannon A. Carty, Ryan A. Wilcox, Carlos A. Murga Zamalloa, Grzegorz S. Nowakowski, Tycel J. Phillips
Journal: Blood
Blood (2022) 140 (Supplement 1): 9510–9511.
https://doi.org/10.1182/blood-2022-158825
Published: 2022
Journal Articles

A Phase 2 Study with Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment for Newly Diagnosed Multiple Myeloma with Upfront Daratumumab-Based Therapy

J Christine Ye, MDMSc, Philip S Boonstra, PhD, Daniel F. Boyer, MD PhD, Larry D. Anderson, MD PhD, Brea C. Lipe, MD, Andrew Kin, MD, Erica L. Campagnaro, MD, Matthew J. Pianko, MD, Moshe Talpaz, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3191.
https://doi.org/10.1182/blood-2019-132204
Published: 2019
Journal Articles

Integrative Next Generation Sequencing of Myeloproliferative Neoplasms and Correlation of Genetic Variations to Disease Severity

Malathi Kandarpa, PhD, Kristen Pettit, MD, Yi-Mi Wu, PhD, Qing Li, MD, Robert Lonigro, Dan Robinson, PhD, Luke F. Peterson, PhD, Philip S Boonstra, PhD, Arul Chinnaiyan, MD, Moshe Talpaz, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4324.
https://doi.org/10.1182/blood-2018-99-113418
Published: 2018
Journal Articles

Ruxolitinib Is Active and Well Tolerated in Adult Patients with Secondary Hemophagocytic Lymphohistiocytosis: Preliminary Results of an Ongoing, Open-Label, Single Center Study

Fares Alsawah, MD BS, MS, Samuel A. Merrill, MD PhD, Paula L. Bockenstedt, MD, Erica L. Campagnaro, MD, Sumana Devata, MD, Scott D. Gitlin, MD, Mark S Kaminski, MD, Alice M. Cusick, MD, Tycel J. Phillips, MD, Suman L. Sood, MD, Moshe Talpaz, MD, Albert Thomas Quiery, MD, Philip S Boonstra, PhD, Asra Z. Ahmed, MD, Ryan A. Wilcox, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1119.
https://doi.org/10.1182/blood-2018-99-116854
Published: 2018
Journal Articles

Multicenter Retrospective Study of Features and Outcomes of Patients with Intravascular DLBCL Treated at Academic Institutions within the United States

Marcus Geer, MD, Maryann Shango, MD, Brian G. Till, MD, Stephen D. Smith, MD, Hashim Abbas, MD, Brian T. Hill, MD PhD, Jason Kaplan, MD, Paul M. Barr, MD, Paolo Caimi, MD, Deborah M. Stephens, DO, Emily Lin, MD, Alex F. Herrera, MD, Evan Rosenbaum, MD, Jennifer E Amengual, MD, Emily Roberts, Philip S Boonstra, PhD, Sumana Devata, MD, Ryan A. Wilcox, MD, Mark S Kaminski, MD, Tycel J. Phillips, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 377.
https://doi.org/10.1182/blood.V130.Suppl_1.377.377
Published: 2017
Journal Articles

The Relationship between Cause of Death in Myelofibrosis and the Dynamic International Prognostic Scoring System

Benjamin Garmezy, MD, Philip S Boonstra, PhD, Malathi Kandarpa, PhD, Moshe Talpaz, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2929.
https://doi.org/10.1182/blood.V130.Suppl_1.2929.2929
Published: 2017
Journal Articles

A Predictive Model for Response in Myelofibrosis Patients Treated with JAK2 Inhibitors: A Study from Three US Academic Centers and a Large Industry-Based Cohort

Kamal Menghrajani, MD, Philip S. Boonstra, PhD, Cecelia Perkins, MPH, Krisstina L. Gowin, DO, Ruben A. Mesa, MD, Jason R. Gotlib, MD, Moshe Talpaz, MD
Journal: Blood
Blood (2016) 128 (22): 4270.
https://doi.org/10.1182/blood.V128.22.4270.4270
Published: 2016
Journal Articles

A New Prognostic Model for Response in Myelofibrosis Patients Treated with JAK2 Inhibitors: A Study from Three US Academic Centers

Menghrajani Kamal, MD, Philip S. Boonstra, PhD, Alissa A. Weber, MD, Cecelia Perkins, MPH, Krisstina L. Gowin, DO, Huong (Marie) Nguyen, MD, Ruben Mesa, MD, Jason R. Gotlib, MD, Moshe Talpaz
Journal: Blood
Blood (2014) 124 (21): 1842.
https://doi.org/10.1182/blood.V124.21.1842.1842
Published: 2014